ABIN111942
antibody from antibodies-online
Targeting: TNFRSF1B
CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN111942 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 1B (TNFRSF1B) antibody
- Antibody type
- Monoclonal
- Antigen
- Partially purified preparations of TNF binding proteins from U937 cells.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- utr1
- Vial size
- 1 mg
- Concentration
- 2.0 mg/ml
- Storage
- Store the antibody (in aliquots) at -20°C. Avoid repeated freeze thaw cycles. Shelf life one year from despatch.
Submitted references Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.
Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.
Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.
Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
Vandenabeele P, Declercq W, Vercammen D, Van de Craen M, Grooten J, Loetscher H, Brockhaus M, Lesslauer W, Fiers W
The Journal of experimental medicine 1992 Oct 1;176(4):1015-24
The Journal of experimental medicine 1992 Oct 1;176(4):1015-24
Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.
Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W
Journal of immunology (Baltimore, Md. : 1950) 1992 Aug 1;149(3):911-7
Journal of immunology (Baltimore, Md. : 1950) 1992 Aug 1;149(3):911-7
Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.
Ryffel B, Brockhaus M, Dürmüller U, Gudat F
The American journal of pathology 1991 Jul;139(1):7-15
The American journal of pathology 1991 Jul;139(1):7-15
Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.
Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T
The Journal of experimental medicine 1990 Nov 1;172(5):1517-20
The Journal of experimental medicine 1990 Nov 1;172(5):1517-20
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R
The Journal of experimental medicine 1990 Feb 1;171(2):415-26
The Journal of experimental medicine 1990 Feb 1;171(2):415-26
Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.
Hohmann HP, Brockhaus M, Baeuerle PA, Remy R, Kolbeck R, van Loon AP
The Journal of biological chemistry 1990 Dec 25;265(36):22409-17
The Journal of biological chemistry 1990 Dec 25;265(36):22409-17
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H
Proceedings of the National Academy of Sciences of the United States of America 1990 Apr;87(8):3127-31
Proceedings of the National Academy of Sciences of the United States of America 1990 Apr;87(8):3127-31
No comments: Submit comment
No validations: Submit validation data